Številke

Bibliografija osebe. Seznam zajema vsa gradiva in ne le tista, kje je oseba mentor.

Magistrska dela (1)

1. Eva Černec: Vpliv ranolazina in trimetazidina na koncentracijo katepsina S v serumu bolnikov s stabilno ishemično boleznijo srca

Druga dela (6)

1. Sabina Ugovšek, Miran Šebeštjen: Lipoprotein(a)—the crossroads of atherosclerosis, atherothrombosis and inflammation
2. Andreja Rehberger Likozar, Aleš Blinc, Katarina Trebušak Podkrajšek, Miran Šebeštjen: LPA genotypes and haplotypes are associated with lipoprotein(a) levels but not arterial wall properties in stable post-coronary event patients with very high lipoprotein(a) levels
3. Andreja Rehberger Likozar, Tina Levstek, Tina Karun, Katarina Trebušak Podkrajšek, Janja Zupan, Miran Šebeštjen: Treatment with PCSK9 inhibitors influences microRNAs expression and changes of arterial wall properties
4. Patricija Lunar, Hana Meglič, Mateja Vehar, Sabina Ugovšek, Andreja Rehberger Likozar, Miran Šebeštjen, Janja Zupan: Effect of PCSK9 inhibitors on regulators of lipoprotein homeostasis, inflammation and coagulation
5. Sabina Ugovšek, Andreja Rehberger Likozar, Tina Levstek, Katarina Trebušak Podkrajšek, Janja Zupan, Slobodan Antonić, Miran Šebeštjen: Gain of function variants in PCSK9 gene in high risk patients after myocardial infarction with increased lipoprotein (a) values and treated with statins
6. Andraž Cerar, Gregor Poglajen, Gregor Zemljič, Sabina Frljak, Neža Žorž, Martina Jaklič, Renata Okrajšek, Miran Šebeštjen, Bojan Vrtovec: SGLT2 inhibitors are associated with left ventricular reverse remodeling in patients with non-compaction cardiomyopathy